Drug company (FDA labeler)
Trifluent Pharma, LLC
NDC labeler code: 73352
What is a labeler?
The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.
Official FDA data only
Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.
Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.
Prescription medicines
- LidocaineXylocaine Mpf, Xylocaine, Lidocaine Viscous · 3 products
- FenofibrateAntara, Lipofen, Tricor · 2 products
- TizanidineZanaflex, Ontralfy · 2 products
- MethocarbamolRobaxin, Atmeksi, Tanlor · 1 product
- Ergotamine tartrate and caffeineCafergot, Migergot · 1 product
- GabapentinNeurontin, Gralise, Relgaabi · 1 product
- CrotamitonPruradik, Eurax, Crotan · 1 product
- HydrocortisoneSolu-Cortef, Proctozone-Hc, Alkindi Sprinkle · 1 product
- Dihydroergotamine mesylateBrekiya, Trudhesa, Atzumi · 1 product
- Dicyclomine hydrochloride1 product
- DiclofenacZipsor, Lofena, Cambia · 1 product
- Econazole nitrateEcoza · 1 product
- BaclofenGablofen, Lyvispah, Baclofen (Intrathecal) · 1 product
FDA applications for these products
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Approved | Application | Medicine | Sponsor |
|---|---|---|---|
| December 6, 2024 | ANDA214445 | Baclofen BACLOFEN | Rubicon Research |
| September 7, 2023 | ANDA217732 | Fenofibrate FENOFIBRATE | Creekwood Pharms |
| June 22, 2023 | ANDA216881 | Dihydroergotamine mesylate DIHYDROERGOTAMINE MESYLATE | Rubicon Research |
| December 14, 2022 | ANDA216736 | Dicyclomine hydrochloride DICYCLOMINE HYDROCHLORIDE | Rubicon Research |
| May 27, 2020 | ANDA213798 | Tizanidine TIZANIDINE HYDROCHLORIDE | Rubicon Research |
| April 30, 2020 | ANDA209190 | Lidocaine LIDOCAINE | Ibsa |
| February 18, 2016 | ANDA204989 | Gabapentin RELGAABI | Sciegen Pharms |
| October 24, 2013 | NDA205175 | Econazole nitrate ECOZA | Resilia Pharms |
| August 23, 2012 | ANDA200675 | Lidocaine LIDOCAINE | Actavis Labs Ut Inc |
| October 21, 2011 | ANDA200958 | Methocarbamol METHOCARBAMOL | Bostal |
| September 16, 2005 | ANDA040590 | Ergotamine tartrate and caffeine ERGOTAMINE TARTRATE AND CAFFEINE | Pharmobedient |
| November 20, 1998 | ANDA075229 | Diclofenac DICLOFENAC POTASSIUM | Rubicon Research |
| April 17, 1992 | ANDA081271 | Hydrocortisone TEXACORT | Mission Pharma |
| December 16, 1981 | ANDA087204 | Crotamiton CROTAN | Legacy |
The sponsor is the company that holds the FDA application; it can differ from the labeler.
Recall timeline
No recall of these products (by NDC code) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026